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Abstract 26 
Melanocortin receptor accessory protein 2 (MRAP2) is a transmembrane accessory protein predominantly 27 
expressed in the brain. Both global and brain-specific deletion of Mrap2 in mice results in severe obesity. 28 
Loss-of-function MRAP2 mutations have also been associated with obesity in humans. Although MRAP2 29 
has been shown to interact with MC4R, a G protein-coupled receptor with an established role in energy 30 
homeostasis, appetite regulation and lipid metabolism, the mechanisms through which loss of MRAP2 31 
causes obesity remains uncertain. In this study we used two independently derived lines of Mrap2 32 
deficient mice (Mrap2tm1a/tm1a) to further study the role of Mrap2 in the regulation of energy balance and 33 
peripheral lipid metabolism. Mrap2
tm1a/tm1a
 mice have a significant increase in body weight, with 34 
increased fat and lean mass, but without detectable changes to food intake or energy expenditure.  35 
Transcriptomic analysis showed significantly decreased expression of Sim1, Trh, Oxt and Crh within the 36 
hypothalamic paraventricular nucleus (PVN) of Mrap2
tm1a/tm1a
 mice.  Circulating levels of both high-37 
density lipoprotein (HDL) and low-density lipoprotein (LDL) were significantly increased in Mrap2 38 
deficient mice. Taken together, these data corroborate the role of MRAP2 in metabolic regulation and 39 
indicate that, at least in part, this may be due to defective central melanocortin signalling. 40 
  41 
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Introduction 42 
Melanocortin receptor accessory proteins, consisting of Melanocortin Receptor Accessory Protein 43 
(MRAP) and its paralogue MRAP2, are a recently identified class of small, single-pass transmembrane 44 
domain accessory proteins (Chan, et al. 2009; Novoselova, et al. 2013). Both MRAP and MRAP2 have 45 
been shown to interact with the melanocortin receptors (MCRs), a family of G protein-coupled receptors 46 
(GPCRs) with diverse physiological function that are stimulated by pro-opiomelanocortin (POMC) 47 
derived peptide agonists such as adrenocorticotropin hormone (ACTH) and α-MSH (Chan et al. 2009; 48 
Cone 2005). Of the five MCRs (MC1R-MC5R), only the function of the melanocortin 2 receptor (MC2R) 49 
is clearly recognized to be facilitated by MRAPs (Chan et al. 2009; Metherell, et al. 2005), although in-50 
vitro data suggests a broader role in conjunction with all the MCRs (Chan et al. 2009; Sebag and Hinkle 51 
2009, 2010).  52 
MRAP is highly expressed in the adrenal gland and is essential for MC2R function. Mutations in MRAP 53 
are associated with familial glucocorticoid deficiency [OMIM#607398] (Metherell et al. 2005).  MRAP2 54 
is predominantly expressed in the central nervous system and hypothalamus, in particular within the 55 
paraventricular nucleus (PVN), a region known to have a role in energy homeostasis (Chan et al. 2009). 56 
Mice with global and brain-specific Mrap2 deletion developed marked obesity and rare loss-of-function 57 
or missense heterozygous variants in MRAP2 were also identified in humans with severe early-onset 58 
obesity (Asai, et al. 2013). This work indicated that MRAP2’s role in the control of body composition and 59 
growth is via MC4R signalling (Asai et al. 2013). Further evidence for a link with Mc4r signaling came 60 
from a study on the role of Mrap2 in zebrafish feeding and growth (Sebag, et al. 2013).  61 
Given these data, the phenotype seen in Mrap2-deficient mice is likely, at least in part, to be driven by 62 
disruption of central melanocortin signaling. However, some areas of uncertainty remain.  In particular, 63 
the paradoxical observation that the mutant mice become obese without detectable changes in food intake 64 
or energy balance (Asai et al, 2013) requires exploration, as does the potential role of MRAP2 in 65 
peripheral cholesterol and lipid metabolism, a function known to be regulated by melanocortins. 66 
(Nogueiras, et al. 2007; Perez-Tilve, et al. 2010). In this study we have used an independently derived 67 
line of Mrap2-deficient mice (Mrap2
tm1a/tm1a
) on two different genetic backgrounds to further study the 68 
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role of MRAP2 in the regulation of energy homeostasis and the control of cholesterol and lipid 69 
metabolism.  70 
Materials and Methods 71 
Generation of Mrap2-deficient mouse 72 
Mice carrying the knockout-first conditional-ready allele Mrap2tm1a(EUCOMM)Wtsi (abbreviated to Mrap2tm1a), 73 
were generated on a C57BL/6N background as part of the Sanger Mouse Genetics Project (MGP) (Fig 74 
1A). Mice carrying the same Mrap2
tm1ai
 allele were generated separately on a 75 
129S5/SvEvBrdWtsi;129P2/OlaHsdWtsi background (abbreviated to 129/Sv). Detailed description of the 76 
Sanger Mouse Genetics Project methodology has been reported (Skarnes, et al. 2011). Briefly, a 77 
promoter-containing cassette (L1L2_Bact_P) was introduced upstream of the critical Mrap2 exon 4 at 78 
position 87175333 of Chromosome 9, Build GRCm38 (Fig 1A). The vectors containing Mrap2tm1a were 79 
electroporated into C57BL/6N derived JM8F6 and 129P2/OlaHsd derived E14Tg2a embryonic stem cells 80 
(ES). Correct ES cell gene targeting was confirmed by long-range PCR and quantitative PCR. Targeted 81 
ES cells were microinjected into blastocysts and used to generate chimeras. Germ-line transmission was 82 
confirmed by genotyping PCR analyses (http://www.knockoutmouse.org/kb/25/). Mice derived from 83 
heterozygous intercross, were genotyped for the Mrap2
tm1a
 allele by PCR (Supplementary Table 1).  84 
Animal husbandry 85 
The care and use of all animals were carried out in accordance with UK Home Office regulations, UK 86 
Animals (Scientific Procedures) Act 1986. Mice were kept under a standard light/dark cycle (12:12) with 87 
food and water ad libitum unless otherwise stated. 129/Sv background mice were maintained in a facility 88 
at 22°C and fed a standard chow (SDS RM3, Essex, UK). Mice on a C57BL/6N background were 89 
maintained at 21°C +/-2°C, humidity 55%+/-10% and fed a standard rodent chow (LabDiets 5021-3, IPS, 90 
Richmond, USA).  91 
Metabolic phenotyping  92 
This was undertaken at two independent centres. In accordance to the 3R (replacement, reduction and 93 
refinement) principles of humane experimental technique and based on scientific objectives, not all 94 
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procedures were performed on both lines. The genetic background of Mrap2
tm1a
 mice used in each 95 
experiment is shown in the text.  96 
Phenotyping using C57BL/6N mice was performed at the Wellcome Trust Sanger Institute as part of the 97 
MGP (White, et al. 2013) whilst studies using 129/Sv background mice were performed at the University 98 
of Cambridge Metabolic Research Laboratories (MRL). For data arising from the MGP, a cumulative 99 
baseline was generated from controls of the same genetic background, age and sex. 7 male and 7 female 100 
Mrap2
tm1a
 mice were processed in 5 batches per sex (1-3 mice per batch) and were phenotyped unblinded 101 
as part of a larger mixed genotype group that included weekly wild-type controls, with the individual 102 
mouse as the experimental unit.  Animals for testing were randomly assigned to test sessions and 103 
operators.  Mice were group housed to a minimum density of 3 per cage.  104 
Body composition of 14-week-old anaesthetised C57BL/6N Mrap2tm1a mice were determined by dual-105 
energy x-ray absorptiometry (DEXA) using a Lunar PIXImus2 mouse densitometer (General Electric 106 
Medical Systems, Fitchburg, WI).  107 
Intraperitoneal glucose tolerance tests (IPGTT) were carried out on 13-week-old mice and performed 108 
after overnight fasting (approximately 16-hours). After taking a baseline glucose measurement, mice were 109 
given a single glucose injection (2g/kg) and blood glucose measured at 15, 30, 60 and 120 minutes (Accu-110 
Chek Aviva, Roche).  111 
Blood for plasma biochemistry was collected from 16-week-old C57BL/6N animals into lithium-heparin 112 
tubes. Animals were not fasted unless indicated. Clinical blood chemistry was performed on an Olympus 113 
AU400 chemistry analyser (Olympus Diagnostics). Insulin levels were measured by Mesoscale Discovery 114 
array technology platform.    115 
Additional data relating to the C57BL/6N Mrap2tm1a/tm1a line can be found at 116 
http://www.mousephenotype.org/data/genes/MGI:3609239. 117 
For studies at MRL, individual experiments were matched for age and sex of mice. The body weight and 118 
length was measured weekly from weaning. Food intake was carried out on 8-week-old single housed 119 
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acclimatized animals. Response to fasting was measured after mice were moved into clean cages, and 120 
food was removed at 07:00 for 24hrs.  121 
Energy expenditure was determined at 8 weeks of age using indirect calorimetry. Animals were placed in 122 
a custom-built monitoring system based on their home cages (Ideas Studio, Cambridge, UK). Oxygen 123 
consumption and carbon dioxide production was measured, and samples taken at 18 min intervals for 124 
48hrs. Energy expenditure was calculated using indirect calorimetry with the Elia and Livesey constants 125 
for respiratory quotient (Elia and Livesey 1992). Activity was assessed by beam breaks (beams 1.25 cm 126 
apart) and measurements taken as total, rather than consecutive beam breaks. 127 
Behavioural Tests  128 
Open field assessment was used to quantify spontaneous locomotor behaviour in a novel environment. 129 
The open field, custom designed walled, infra-red backlit arena 75cm2 (Tracksys Ltd., UK) was 130 
subdivided into a centre zone (42 cm
2
) with the remainder designated as border zone. 20-week-old 129/Sv 131 
background mice were recorded for a 20 minute period using Noldus Ethovision-3 video tracking 132 
software. The position of the centre-point of the mouse within the open field was recorded. A mouse was 133 
considered to begin moving when its velocity surpassed 2cm/sec and stop moving when below 134 
1.75cm/sec.  Mrap2
tm1a/tm1a
 and their Mrap2
+/+
 controls were littermates housed in single-sex groups of 3-135 
5.  136 
Histology, non-radioactive in-situ hybridization, immunohistochemistry and PVN stereotaxic 137 
counts 138 
For hematoxilin-eosin (H&E) staining, tissues were fixed in 4% paraformaldehyde [PFA] (Sigma), 139 
washed, dehydrated and embedded into paraffin before sectioning to 7µm. For Oil-Red-O staining flash 140 
frozen liver was embedded into OCT (VWR), 10 µm cryosections were adhered onto slides 141 
(ThermoFisher) and stained with Oil-Red-O (Sigma). Both staining techniques were performed according 142 
to standard protocols. Ucp1 immunohistochemistry was performed using brown fat paraffin sections, anti-143 
Ucp1 antibody (1/500) according to the manufacturer’s instructions (ab10983, Abcam) followed by 144 
detection using anti-rabbit HRP antibody (Thermo-Fisher) with DAB staining (Vector).  145 
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To generate riboprobes for in-situ hybridization (ISH), RNA was extracted from hypothalamus and 146 
cDNA prepared. Full-length Mrap2 cDNA fragment (898 bp) was PCR amplified (Supplementary Table 147 
1), ligated into pGEM-T easy vector (Promega), sequenced, then linearized with EcoRI or NotI 148 
(Promega). Digoxigenin (DIG)-labelled antisense and sense cRNA probes were synthesized by in-vitro 149 
transcription with T7 or SP6 RNA polymerases (Roche). Dissected brains were embedded into OCT and 150 
frozen in liquid nitrogen, 20µm cryosections were cut onto slides and fixed with ice-cold 4% PFA for 20 151 
min. Slides were then subjected to ISH as described previously (Gorrigan, et al. 2011).  152 
For the PVN neuron counts, Mrap2tm1a/tm1a and wild-type littermates (3 brains per group), were fixed in 153 
4% PFA, cryoprotected with 20% sucrose and cryosectioned 20µm each starting from −0.58mm  to −1.22 154 
mm to bregma (Franklin and Paxinos 2012). After Nissl staining, the slides were visualized and images 155 
taken using Zeiss Axio Scope A1. The neurons within the PVN were then counted using ImageJ software 156 
(http://imagej.nih.gov/ij/).  157 
Laser-captured microdissection and RNA isolation 158 
Mouse brains from 9-week-old, 129/Sv Mrap2tm1a/tm1a and Mrap2+/+ mice were dissected, immediately 159 
embedded into OCT and frozen in liquid nitrogen. 20 µm coronal sections covering the region from −0.58 160 
to −1.22 mm caudal to bregma (Franklin and Paxinos 2012) were cut on a cryostat and mounted on 161 
Superfrost™ Plus slides (Thermo-Fisher). Frozen sections were fixed for 40s in 95% ethanol and then 162 
rehydrated (75 and 50% ethanol, 30s each). The slides were stained with 1% cresyl violet in 75% ethanol 163 
(w/v) for 45s, dehydrated in a graded ethanol series (50%, 75%, 95%, 100% for 30s each), in 100% 164 
ethanol for 5 min and air-dried. Laser microdissection was performed using a P.A.L.M. MicroBeam 165 
(Zeiss). The PVN was collected into AdhesiveCap tubes (Zeiss). Total RNA was immediately isolated 166 
using the RNAqueous-Micro kit (Ambion). Quality and quantity of the total RNA samples were 167 
determined by the Agilent BioAnalyzer using PicoChip. RNAse free technique and RNAase free reagents 168 
were used throughout. 169 
RNA microarray hybridization and analysis   170 
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15ng of isolated RNA with the RNA Integrity Number of at least 6.5 (n=4 for Mrap2
+/+
; n=3 for 171 
Mrap2tm1a/tm1a) was converted into cDNA using Ovation PICO SL System V2 (NuGEN) which was then 172 
fragmented and labelled using Encore® BiotinIL Module (NuGEN). 1500ng of each labelled product was 173 
then hybridised with MouseRef-8v2.0 Expression BeadChip Kit according to the manual and scanned 174 
using iScan (Illumina). Raw image data were converted to bsc format using Illumina GenomeStudio 175 
2011.1® software. Bonferroni correction with Family-Wise Error Rate (FWER) of 0.05 was applied to 176 
identify statistical significance of gene expression changes. Pathway analysis was performed using 177 
DAVID6.7® (http://david.abcc.ncifcrf.gov/tools.jsp) and STRING 10® (http://string-db.org/). 178 
Quantification of RNA by real-time quantitative PCR (Q-RT-PCR) 179 
Dissected tissues were immediately frozen in liquid nitrogen, homogenized using Precellys
®
24 180 
(Precellys) into RPL buffer (Qiagen) and the RNA extracted with RNeasy Mini Kit (Qiagen). cDNA was 181 
produced with SuperScript™II (Life Technologies) and 50ng of cDNA used for RT-Q-PCR with 182 
TaqMan® Universal MasterMix II and gene specific TaqMan® probes (Life technologies, Supplementary 183 
Table 2). The fold change in relation to Actin-b was calculated using 2-∆∆Th method (Livak and 184 
Schmittgen 2001).  185 
Protein quantification  186 
White and brown fat tissue was homogenised using Precellys®24 in ice-cold RIPA buffer (Sigma) 187 
containing Phosphotase (Roche) and Protease Inhibitors cocktail (Sigma). Lysates were centrifuged for 20 188 
min at 4ºC before separation of the lipid layer. The SDS-PAGE samples were prepared with 2XSample 189 
buffer (Sigma), heated at 95ºC for 5 min, centrifuged for 20 min at 4ºC to separate samples from residual 190 
lipids and subjected to Western Blotting. The membrane was blocked with 5% bovine serum albumin in 191 
TBS (Life Technologies) for 1 hour at 22ºC followed by incubation at 4ºC overnight with the primary 192 
antibody: anti-ACTB antibody 1/10000 (Abcam), anti-UCP1 1/5000 (Abcam) and antibodies for Fatty 193 
Acid and Lipid Metabolism and Lipolysis Activation (8334, 8335 Cell Signaling Technology).  After 194 
three washes the membranes were probed with anti-mouse 680 and anti-rabbit 800 IRDye antibodies (LI-195 
COR). The band intensities were quantified using Odyssey® software.  196 
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Statistics  197 
All data generated from the MGP utilised statistical analysis with RStudio running R version 3.1.2 and 198 
Phenstat package version 2.0.1. This uses a mixed-model framework (Karp, et al. 2012) to assess the 199 
impact of genotype on phenotype. The analysis was performed by loading the model without body weight 200 
thereby analysing the absolute differences between genotypes whilst accounting for sex, using the model: 201 
Y=Genotype+Sex+Genotype*Sex. Multiple correction testing was performed on the global p-values 202 
using the Hochberg correction. Data is presented as both box-and-whiskers plot (showing min-mean-max 203 
values, with the box representing the 25th and 75th percentiles), and as a scatter dot plot for individual 204 
values. P-values presented on graphs are either global p-values for genotype adjusted for multiple 205 
correction testing, or (in the cases of sexual dimorphism) the p-value is the impact of genotype for that 206 
sex.  207 
For other data males and females were assessed independently and the effect of genotype compared to 208 
wild-type controls was statistically tested using a two-tailed Student’s t-test. For calorimetry data, 209 
multiple linear regression analysis  (ANCOVA) was used. Data is plotted as mean +/- S.E.M and 210 
analysed using Microsoft excel and GraphPad Prism.  211 
Results 212 
Production of Mrap2-deficient mice  213 
Mice carrying the mutant Mrap2
tm1ai
 allele were viable with expected homozygous mutant offspring born 214 
from heterozygous matings (21% C57BL/6N Mrap2tm1a/tm1a and 23% 129/Sv Mrap2tm1a/tm1a). Both female 215 
and male Mrap2tm1a/tm1a mice were fertile and did not exhibit any changes in skin or hair color/appearance. 216 
The introduction of the knockout-first Mrap2
tm1a
 allele resulted in targeted disruption of the critical exon 217 
4 encoding the transmembrane domain of the protein. The predicted outcome would be a premature stop 218 
codon thus producing a short 132bp transcript that, if translated, would produce a 44 amino acid protein 219 
(predicted MW 5kDa). Previous work demonstrated that such a protein was unlikely to be translated 220 
(Asai et al. 2013). However, generation of hypomorphic mice have previously been demonstrated using 221 
the “knockout-first” strategy targeting other genes (Chen, et al. 2013; McIntyre, et al. 2012; White et al. 222 
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2013). We therefore determined the expression of Mrap2 by Q-RT-PCR analysis using a TaqMan® probe 223 
spanning exons 4-5. cDNA generated from whole hypothalamus derived from mice on an 129/Sv 224 
background revealed a low but detectable residual Mrap2 transcript of Mrap2tm1a/tm1a  within homozygous 225 
mice (13%, range 11-16%), whilst heterozygotes Mrap2
tm1a/+
 mice had approximately half of the Mrap2 226 
transcript expression compared with Mrap2+/+ (Fig 1B).   227 
Mrap2 is predominantly expressed in the paraventricular nucleus of the hypothalamus 228 
Mrap2 RNA expression was studied in wild-type mice tissues (Fig 1B). The highest expression level was 229 
detected in the hypothalamus with substantial expression seen in the pituitary gland.  Mrap2 expression 230 
was also detected in the cortex, cerebellum and adrenal gland. Kidney, testes, thymus and pancreas had 231 
very low expression levels whilst expression in white fat, liver, brown fat and skin was undetectable (Fig 232 
1B). ISH using a full length Mrap2 probe showed visible Mrap2 RNA expression in the PVN of 233 
Mrap2
+/+
 mice on a 129/Sv background, which was absent in Mrap2
tm1a/tm1a
 mice (Fig 1C).  234 
Mrap2 deficiency results in obesity in both C57BL/6N and 129/Sv background 235 
Prior to weaning there was no difference in body weight between wild-type and Mrap2tm1a/tm1a mice (Fig 236 
1D). However, in both genetic backgrounds and in both sexes, Mrap2
tm1a/tm1a
 mice had a significant 237 
increase in body weight from 6 weeks of age. By 16 weeks of age on a C57BL/6N background, mean 238 
body weight in male wild-type mice was 32.2g, compared to 42.5g in Mrap2tm1a/tm1a mice; the 239 
corresponding weights in females were 25.4g and 38.7g, respectively (Fig 1E). Similarly on a 129/Sv 240 
background, mean body weight in male wild-type mice was 29.1g, compared to 45.1g in Mrap2tm1a/tm1a 241 
mice; the corresponding weights in females were 24.4g and 36.9g, respectively. 242 
In C57BL/6N, this increase in body weight was as a result of a significant increase in both fat and lean 243 
mass (Fig 2A,D). C57BL/6N Mrap2tm1a/tm1a females had twice the fat/body weight ratio of Mrap2+/+ 244 
controls and Mrap2tm1a/tm1a males displayed a 1.5 fold increase (Fig 2A,B) with clear increase in adipocyte 245 
size macroscopically (Fig 2C). There was no difference in bone mineral content or density observed in 246 
either sex (Fig 2E). Body length was significantly increased in female, but not male Mrap2tm1a/tm1a mice 247 
(Fig 2F). On the 129/Sv background, a significant increase in fat mass was recorded in both male and 248 
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female Mrap2
tm1a/tm1a
 mice compared to wild-type controls with no change in lean mass observed (data 249 
not shown). 250 
Mrap2-deficient mice display little difference in food intake and energy expenditure compared with 251 
wild-type control mice  252 
Activation of the melanocortin system has a role in both feeding behaviour in both ad libitum conditions 253 
and in re-feeding after fasting. To determine if loss of Mrap2 affects feeding behaviour in either situation, 254 
the food intake and body weight of 8-week-old male and female 129/Sv mice was monitored over a 255 
period of 60-hours. For the first 24-hours food was freely available, after which mice were fasted for 24-256 
hours followed by reintroduction of food (Fig 3A-3D).  257 
Neither female nor male Mrap2
tm1a/tm1a 
mice exhibited changes in food intake when compared with wild-258 
type controls over the entire period. Further, Mrap2tm1a/tm1a mice did not show any difference in the rate of 259 
weight loss upon fasting compared to the wild-type mice. However, interestingly, during re-feeding after 260 
a fast, Mrap2
tm1a/tm1a 
male mice did not re-gain weight as fast as the wild-type males (Fig 3C,D). 261 
Total energy expenditure measurements versus lean mass or total body weight did not show significant 262 
changes between the genotypes/sex (Supplementary Fig 1). Analysis of respiratory quotient over a period 263 
of 48-hours demonstrated that it did not differ between Mrap2
tm1a/tm1a
 and their Mrap2
+/+
 littermates 264 
(Supplementary Fig 2). In keeping with a lack of change in energy expenditure there was no difference 265 
between Mrap2
tm1a/tm1a
 and Mrap2
+/+
 mice in the expression level of Ucp1 mRNA and UCP1 protein 266 
levels in brown adipose tissue of age-matched animals, despite differences in morphology. 267 
(Supplementary Fig 3). 268 
Locomotor activity measurements (average beam breaks in a 5 minute time period) demonstrated that 269 
male 129/Sv Mrap2tm1a/tm1a mice, compared to wild-type, moved significantly more during the daytime 270 
(Fig 4A). No difference was observed in females.  271 
 272 
Mrap2
tm1a/tm1a
 mice display behavioural changes when presented with a novel environment 273 
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To further examine the locomotor activity as well as novel environment exploration and anxiety-related 274 
behaviour, 20-week-old 129/Sv Mrap2tm1a/tm1a mice were subjected to an open field exploration test 275 
during the light phase. This recapitulated the sex-specific difference in locomotor activity between female 276 
and male Mrap2
tm1a/tm1a
 mice (Fig 4B&C). Mrap2
tm1a/tm1a
 male mice spent more time moving and covered 277 
a greater distance compared with Mrap2+/+ mice.  Although Mrap2tm1a/tm1a male mice appeared to spend 278 
more time traversing the centre of the open field than controls, the difference was not significant, p=0.075 279 
(Fig 4C&D). There was no difference in thigmotactic behaviour in the females and Mrap2
tm1a/tm1a
 mice of 280 
both sexes displayed no differences in gait, circling and rearing behaviour (data not shown). 281 
Mrap2-deficient mice are Sim1 deficient 282 
To further explore what might be driving changes in body composition in Mrap2-deficient mice, we 283 
undertook transcriptomic analysis of laser microdissection PVN from 9-week old 129/Sv Mrap2tm1a/tm1a 284 
mice and wild-type littermates (Fig 5A). Mice on a 129/Sv genetic background, less prone to developing 285 
obesity related co-morbidity, were used to reveal the effect of Mrap2 deficiency without secondary 286 
changes caused by hyperinsulinaemia and/or elevated glucose. We confirmed changes seen in laser 287 
capture material by undertaking Q-RT-PCR on whole hypothalamus derived from a separate, second 288 
population of 129/Sv Mrap2tm1a/tm1a mice and wild-type littermates. Expression of genes that did not show 289 
any changes by microarray, such as Sf-1 and Pomc, were also confirmed by Q-RT-PCR as additional 290 
controls (Supplementary Fig 4). 291 
We could not detect significant changes in Mc4r mRNA expression in the PVN of Mrap2tm1a/tm1a mice due 292 
to the high variability between mice within each group (Fig 5B). However, we found that Sim1 mRNA 293 
level in the PVN of Mrap2
tm1a/tm1a
 mice was <50% of that seen in wild-type littermates (Fig 5C). Sim1 is 294 
responsible for the late stages of the differentiation of oxytocin (Oxt), arginine vasopressin (Avp), 295 
corticotrophin-releasing hormone (Crh), thyrotropin-releasing hormone (Trh) and somatostatin neurons 296 
(Sst) (Michaud, et al. 1998). In keeping with this, in Mrap2
tm1a/tm1a
 mice, PVN expression levels of Oxt, 297 
Avp, Trh and Crh were significantly decreased compared to the wild-type. Sst expression in Mrap2tm1a/tm1a 298 
was unchanged compared with Mrap2+/+ mice, although results were variable within the cohort (n=3 per 299 
group). Analysis of RNA from whole hypothalami (Fig 5D) recapitulated these findings, except for Crh 300 
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expression levels, which did not reach statistical significance. All changes were confirmed in both sexes 301 
(data not shown).  302 
It is known that SIM1 is implicated in the development of the PVN and Sim1+/- mice exhibit a smaller 303 
PVN with reduced neuron number compared to their wild-type littermates (Michaud, et al. 2001). We 304 
could not find morphological changes or a reduction in the number of neurons in the PVN of 305 
Mrap2tm1a/tm1a mice compared to wild-type (Fig 5E&F), suggesting that unlike Sim1+/-, a lack of Mrap2 306 
does not cause underdevelopment of the PVN. 307 
Mrap2 deficiency increases circulating HDL and LDL cholesterol  308 
Macroscopically, the livers of Mrap2
tm1a/tm1a
 mice were visibly pale in both sexes in both 129/Sv and 309 
C57BL/6N backgrounds, and the histological analysis showed lipid accumulation (Fig 6A&B). There is 310 
recent evidence that the central melanocortin system directly controls peripheral lipid metabolism and 311 
circulating cholesterol (Nogueiras et al. 2007; Perez-Tilve et al. 2010). We therefore studied the 312 
cholesterol and lipid profile in C57BL/6N Mrap2
tm1a/tm1a
 mice. The blood triacylglyceride levels (TAG) 313 
were not significantly different in Mrap2tm1a/tm1a mice compared with wild-type (Fig 6C). However total 314 
circulating cholesterol in Mrap2
tm1a/tm1a
 mice was significantly higher than in wild-type controls of both 315 
sexes (Fig 6D). High-density lipoprotein (HDL) was elevated in both sexes with a greater percentage 316 
increase in females (Fig 6E). Low-density lipoprotein (LDL) was significantly increased in male and 317 
female Mrap2
tm1a/tm1a
 mice (Fig 6F). NEFA-C levels were not significantly different between 318 
Mrap2tm1a/tm1a and Mrap2+/+ mice of either sex (Fig 6G), whilst glycerol concentration was increased to a 319 
similar degree in mutant mice of both sexes (Fig 6H). To investigate whether high cholesterol levels were 320 
due to a decrease in cholesterol re-uptake in the liver or an increase in cholesterol synthesis, we analysed 321 
the expression of the HDL scavenger receptor Scarb1, LDL receptor (Ldlr) and the key transcription 322 
factor of cholesterol biosynthesis Srebp2 (Shimomura, et al. 1998) in the livers of 129/Sv Mrap2tm1a/tm1a 323 
mice. Interestingly, Srebp2 mRNA levels were increased in the livers of female Mrap2
tm1a/tm1a
 mice 324 
whereas Scarb1 and Ldlr levels were similar to the wild-type (Fig 6I). Expression analysis of livers from 325 
male Mrap2tm1a/tm1a mice showed lower levels of Ldlr mRNA whereas Scarb1 and Srebp2 transcript were 326 
similar to the wild-type male littermates (Fig 6I). 327 
Page 13 of 33
14 
 
To study white fat function we tested the protein levels and phosphorylarion state of enzymes involved in 328 
lipogenesis and fatty acid synthesis as well as phosphorylation of the rate-limiting enzyme for lipolysis 329 
Hormone Sensitive Lipase (HSL). Phosphorylation of ATP-citrate lyase (ACL), an enzyme responsible 330 
for the synthesis of cytosolic acetyl-CoA that then serves lipogenesis and cholesterolgenesis pathways 331 
(reviewed in (Chypre, et al. 2012)), was increased in white fat of female Mrap2tm1a/tm1a mice but not in 332 
Mrap2tm1a/tm1a male mice (Fig 7A&B, Supplementary Fig 5A&B).  333 
HSL phosphorylation is known to be important for the enzyme activation and therefore lipolysis (Egan, et 334 
al. 1992). The proportion of HSL phosphorylated on S563, S565 and S660 was analysed and it was found 335 
that the proportion of S660 phosphorylated HSL was 3 times lower in white fat of female Mrap2
tm1a/tm1a
 336 
mice compared to the wild-type (Fig 7C&D). Phosphorylation on other residues was not changed and 337 
male Mrap2tm1a/tm1a mice did not have changes in HSL phosphorylation on any residues tested 338 
(Supplementary Fig 5C-F). 339 
Analysis of glucose homeostasis in Mrap2-deficient mice  340 
Mrap2tm1a/tm1a mice of both sexes on a C57BL/6N background fed on a chow diet from weaning display 341 
elevated fasting plasma insulin concentration with higher fasting blood glucose at 13 weeks of age 342 
compared to Mrap2
+/+
 mice (Fig 7E,F). Glucose clearance in response to an IP glucose bolus (Fig 7G,H) 343 
appeared delayed although statistical analysis of the area under the curve was only significant in female 344 
mice.  345 
Discussion 346 
In this study, we report the generation and characterization of a murine model with a targeted Mrap2 347 
allele (knockout-first Mrap2
tm1a(EUCOMM)Wtsi
). The construct used here is a tm1a allele, which theoretically 348 
can still allow transcriptional read through (White et al. 2013). We detected low Mrap2 expression within 349 
Mrap2tm1a/tm1a homozygous mice and in the absence of a suitable antibody we cannot rule out the 350 
possibility that the animals studied were indeed “strong hypomorphs” rather than of complete knockouts.  351 
Mrap2tm1a/tm1a mutant mice on both C57/BL6N and 129/Sv background display severe early-onset obesity 352 
with a significantly increased fat mass, consistent with a recent report of Mrap2 knockout mice (Asai et 353 
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al. 2013). Unlike Mrap2
-/-
 mice on a 129/Sv genetic background (Asai et al. 2013), our C57BL/6N 354 
Mrap2tm1a/tm1a display elevated fasting insulin and blood glucose concentrations. We believe that this is 355 
evidence of an interesting interaction between the genetic backgrounds with Mrap2, which will form the 356 
basis of a future study. 357 
Mrap2-/- mice have previously been reported to show no increased food intake or reduction in energy 358 
expenditure and thermogenesis to account for their increased body weight. In our assessment of 8 weeks 359 
old Mrap2
tm1a/tm1a
 mice, we recapitulated and confirmed these findings. We calculate that female 360 
Mrap2tm1a/tm1a mice gained more weight compared to the wild-type mice (females: 0.117±0.041 g/day; 361 
males: 0.096±0.023 g/day). To achieve this a female mutant mouse would need to deposit 0.701±0.246 362 
kcal/day and a male mouse 0.578±0.139 kcal/day (Flatt 1991).  This would equate to an increase in food 363 
intake of 0.232±0.081g of standard chow (for females) and 0.191±0.046g (for males), which is within the 364 
measurable limits of food intake variation. Therefore, it is possible that the causative difference is below 365 
the threshold of the detection (Speakman 2013; Tschop, et al. 2012). Indeed, older animals that are 366 
significantly more obese than their wild-type counterparts, and as a result would be expected to consume 367 
larger quantities, demonstrate a subtle increase in cumulative food intake when monitored over 50 days 368 
(Asai et al. 2013). Additionally, our behavioural tests on separate cohorts of animals, independently 369 
analysed on two separate platforms demonstrated sex specific increased daytime locomotor and 370 
exploratory activity in Mrap2
tm1a/tm1a 
male mice, which may indicate food-seeking behaviour. These lines 371 
of evidence would point to hyperphagia being the key driver to the development of obesity. However 372 
importantly, obesity in Mrap2 deficient animals clearly preceed any change in food intake and in paired 373 
feeding studies Mrap2 deficient animals continue to gain more weight than their wild-type counterparts 374 
(Asai et al. 2013). It is only when further food restriction was undertaken did weight gain in mutant mice 375 
become equivalent to that of wild-type mice (Asai et al. 2013). Intriguingly, this suggests a far more 376 
complex mechanism at play in Mrap2 null mice.  377 
Our transcriptomic analysis of the PVN of the mutant mice also favoured increased energy intake as 378 
being a more likely promoter of increased body weight. It was found that Sim1 expression levels were 379 
low in the PVN of the Mrap2
tm1a/tm1a
 mice resembling Sim1 deficiency. The reduced expression of Sim1 380 
and its associated neuropeptides cannot be secondary to obesity alone, as this was not observed in 381 
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reported hypothalamic microarray data from obese mice fed in a high fat diet (Lee, et al. 2010). SIM1 is a 382 
transcription factor that regulates development of the PVN, and Sim1-/- mice die due to the abnormal 383 
hypothalamic architecture (Michaud et al. 2001). Heterozygous Sim1+/- mice exhibit a small PVN with 384 
reduced neuronal number and develop severe early-onset obesity due to hyperphagia and increased linear 385 
growth. They have an impaired response to MTII, a MC3R/MC4R agonist, indicative of a disrupted 386 
central melanocortin pathway (Holder, et al. 2004; Kublaoui, et al. 2006a; Kublaoui, et al. 2006b; Tolson, 387 
et al. 2010). Expression analysis of the PVN from Sim1
+/-
 mice has shown an 80% decrease in Oxt 388 
expression and 20–40 % decrease in Trh, Crh, Avp  and Sst expression (Kublaoui, et al. 2008). Compared 389 
to Sim1
+/- 
mice, we did not detect morphological changes within the PVN of Mrap2
tm1a/tm1a 
mice. 390 
However, the levels of Oxt, Avp and Trh in Mrap2
tm1a/tm1a
 mice PVN were reduced, consistent with low 391 
Sim1 expression levels. Interestingly, despite these changes and also the high expression of Mrap2 in the 392 
pituitary, we found no evidence of pituitary dysfunction in Mrap2
tm1a/tm1a
 mice. Progression through 393 
puberty and fertility appear unchanged in mutant mice and thyroid hormone levels, T3 and T4, were 394 
normal (data not shown). Corticosterone concentrations were previously reported to be normal (Asai et al. 395 
2013). This would suggest that the level of neuropeptide expression is sufficient for peptide production 396 
and physiological stimulation of downstream hormones, as exemplified by normal levels of T4 in the case 397 
of Trh.  398 
In contrast to the downstream effects, the change in neuropeptide expression is likely to play a direct role 399 
in maintaining energy homeostasis as it is known that Oxt, Avp and Trh in the PVN have anorexigenic 400 
effects (reviewed in (Valassi, et al. 2008)), and Oxt is thought to be key to the mechanism for the 401 
hyperphagia of Sim1
+/−
 mice (Kublaoui et al. 2008). Overall, the changes in Sim1 provide further 402 
evidence that a central melanocortin pathway deficiency exists in Mrap2tm1a/tm1a mice as SIM1 has been 403 
considered to be downstream of MC4R signalling (Holder et al. 2004; Kublaoui et al. 2006a; Kublaoui et 404 
al. 2006b; Tolson et al. 2010).  405 
Modulation of MC4R has been shown to directly affect peripheral lipid metabolism. Mc4r-/- mice have 406 
elevated plasma cholesterol and HDL levels (Nogueiras et al. 2007; Perez-Tilve et al. 2010). Both sexes 407 
of Mrap2
tm1a/tm1a 
mice display elevated circulating cholesterol although there is a suggestion that males 408 
and females partition cholesterol into HDL differently, consistent with reports of sex differences in the 409 
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hepatic control of cholesterol metabolism (De Marinis, et al. 2008). Mrap2
tm1a/tm1a
 female mice showed 410 
increased de novo hepatic lipogenesis; however, unlike female Mrap2tm1a/tm1a mice, male Mrap2tm1a/tm1a 411 
mice had low expression of liver LDL receptor possibly reflecting elevated circulating LDL levels.  412 
Mrap2
tm1a/tm1a
 female mice have increased ACL phosphorylation in white fat, a key modification that 413 
activates ACL catalytic activity (Berwick, et al. 2002) and leads to an increase in de novo lipogenesis. 414 
Along with this change we found that phosphorylation of HSL on S660, which is phosphorylated by 415 
protein kinase A upon sympathetic nervous system activation (Anthonsen, et al. 1998), was decreased. It 416 
is possible that both changes in the liver and white adipocytes are due to the low sympathetic tone which 417 
is in part regulated via the central melanocortin system (Nogueiras et al. 2007; Perez-Tilve et al. 2010). 418 
Mrap2 is not expressed in white fat or liver and therefore is unlikely to influence de novo lipogenesis 419 
directly in these tissues, suggesting that MRAP2 may contribute to the melanocortin regulation of 420 
sympathetic outflow. The changes observed in white fat were only found in females and are thus unlikely 421 
to be the primary cause of MRAP2-associated obesity, although this might explain the greater severity of 422 
obesity in females. 423 
Our study corroborates the role of MRAP2 in metabolism. The changes in cholesterol metabolism and 424 
transcriptomic profile in the PVN of Mrap2
tm1a/tm1a
 mice support the notion that MRAP2 is involved in the 425 
MC4R signaling pathway in-vivo. However, our data further highlights phenotypic differences between 426 
Mrap2
 
deficient and Mc4r
 
deficient mice. Despite both mice developing severe early-onset obesity, Mc4r
-
427 
/- mice are clearly hyperphagic with decreased energy expenditure (Balthasar, et al. 2005; Huszar, et al. 428 
1997) whilst Mrap2 deficient mice display no demonstrable hyperphagia or reduction in energy 429 
expenditure. We describe other additional phenotypic differences such as normal bone mineral content 430 
and density in Mrap2tm1a/tm1a mice in contrast to increased bone density in Mc4r-/- mice (Braun, et al. 431 
2012). Importantly, Asai et al demonstrated that Mrap2-/- mice remain responsive to treatment with MTII, 432 
a MC3R/MC4R agonist, whilst the anorexic response to MTII is abolished in Mc4r
-/-
 mice, suggesting at 433 
least some preservation of MCR function centrally (Asai et al. 2013; Marsh, et al. 1999). We also show 434 
sex-specific differences in glucose handling as well as an exploratory activity phenotype in Mrap2tm1a/tm1a 435 
mice. Taken together our study points towards the likelihood of MC4R independent mechanisms and 436 
possibly MCR independent pathways in the pathogenesis of MRAP2 associated obesity. 437 
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Figure 1. Mrap2 gene disruption results in weight gain (A) Schematic of knockout first strategy for Mrap2. 
A promoter driven cassette including lacZ and neo genes are inserted upstream of critical exon 4. (B) Q-RT-
PCR in 129/Sv mice demonstrating (i) Mrap2 expression in a range of wild type mouse tissues showing the 
highest expression levels in the hypothalamus, n=3. (ii) reduced hypothalamic Mrap2 transcript  in 
Mrap2tm1a/+ and Mrap2tm1a/tm1a compared with Mrap2+/+ mice (n=3 per genotype); mean plotted +/- 
SEM; ** p-value <0.05; *** p-value <0.0005). (C) Expression of Mrap2 in the hypothalamus of the wild 
type 129/Sv Mrap2+/+ and Mrap2tm1a/tm1a mice as shown by in situ hybridisation using coronal brain 
sections (approx. bregma – 0.6mm). AS- antisense probe, S-sense probe as a negative control. 3rd ventricle 
indicated as 3V, asterisk indicates position of the PVN, OC - optic chiasm; scale bars = 200µm (D) Weight 
curves of Mrap2tm1a/tm1a in both genders and genetic backgrounds illustrated. 129/Sv Mrap2tm1a/tm1a 
n>8 per genotype and gender, C57BL/6N Mrap2tm1a/tm1a n=7 of each gender and genotype. (E) Total 
body weight gain of C57BL/6N Mrap2tm1a/tm1a mice by the age of 16 weeks, n=7 for each 
gender/genotype (left) and appearance of the mutant mice compared to the wild type (right). Data is present 
as both box-and-whiskers plot (showing min-mean-max values, with the box representing the 25th and 75th 
percentiles), and as a scatter dot plot for individual values. P-values presented on graphs are either global p-
values for genotype adjusted for multiple correction testing, or (in the cases of sexual dimorphism) the p-
value is the impact of genotype for that sex. 
 
Figure 2. Increased fat content and lean mass in Mrap2tm1a/tm1a mice at 14 weeks (A) Increased fat mass 
in mutant C57BL/6N mice. (B) Fat mass represented as a % of body weight (C) Adipocyte hypertrophy as 
demonstrated by H&E histology of peripheral fat (representative image of inguinal white fat from 129/sv 
mice). Scale bars = 200µm. (D) Increased lean mass and (E) no difference in bone mineral density or content 
(data not shown) in Mrap2tm1a/tm1a mice (C57BL/6N) compared to Mrap2+/+. (F) Increased body length 
in the female mutant mice only (C57BL/6N). n=7 for each Mrap2tm1a/tm1a group, 34 for female Mrap2+/+ 
and 35 for Mrap2+/+ controls gender/genotype.  P-values presented on graphs are either global p-values for 
genotype adjusted for multiple correction testing, or (in the cases of sexual dimorphism) the p-value is the 
impact of genotype for that sex. 
 
Figure 3. Food intake and energy expenditure balance in Mrap2+/+, Mrap2tm1a/+ and Mrap2tm1a/tm1a 
mice. Body weight dynamics of female (A, Mrap2+/+ n=6; Mrap2tm1a/+ n=4; Mrap2tm1a/tm1a n=10) and 
male (B, Mrap2+/+ n=6; Mrap2tm1a/+ n=7; Mrap2tm1a/tm1a n=6) mutant mice and their food intake (C 
and D) in response to a 24 hour fast (129/Sv background).   
 
Figure 4. Male Mrap2tm1a/tm1a mice locomotor activity analysis. (A) Beam breaks/5 min in male (left, 
Mrap2+/+ n=9; Mrap2tm1a/+ n=7; Mrap2tm1a/tm1a n=11) and female (right, Mrap2+/+ n=6;  
Mrap2tm1a/+ n=4; Mrap2tm1a/tm1a n=10) mice are shown, with male Mrap2tm1a/tm1a mice 
demonstrating significantly increased locomotor activity in their home cages during the daytime (B) Open 
field assessment of Mrap2tm1a/tm1a mice also indicate a significant increase in total time moving and 
distance travelled over 20 min in males (left), when compared to Mrap2+/+ littermates, but not females 
(right). (C) Representative activity traces of the centre-point of individual male mice (left) and female mice 
(right) in the open field. The colour of the trace indicates the velocity of the mouse from 0 cm/sec (blue) to 
20cm/sec (pink). The centre of the open field is indicated by a dashed box.  (D) Neither male (left) nor 
female Mrap2tm1a/tm1a mice (right) display a significant difference in time spent in areas of the open field, 
compared to wild-type controls. n number for B-D is 8 per group/gender, * p-value<0.05. 
 
 
Figure 5. Mrap2 is involved in Mc4r regulation in the hypothalamus. (A) An example of the hypothalamic 
section stained with cresyl violet before the microdissection (left panel) and after (right panel). Asterisks 
show the position of the PVN, 3V-third ventricle, the scale bars are 150µm. (B) Mc4r expression level in the 
PVN (Mrap2+/+ n=3, Mrap2tm1a/tm1a n=3) and in the whole hypothalamus (Mrap2+/+ n=4, 
Mrap2tm1a/tm1a n=4) as determined by the qPCR. (C) Expression of Sim1, Trh, Oxt, Avp, Crh and Sst in 
the PVN of 129/Sv wild type (n=4) and Mrap2tm1a/tm1a (n=3) mice. The data is represented as the mean of 
the microarray fluorescence values (±S.E.M), normalised to the wild type for each gene. *p-value <0.05; ** 
p-value <0.05; *** p-value <0.0005 (D) Expression of Sim1, Trh, Oxt, Avp, Crh and Sst in the whole 
hypothalamus of the wild-type and Mrap2tm1a/tm1a mice as determined by the qPCR. Data from male mice 
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n=4 per genotype is shown. The graph represents mean±S.E.M. *p-value <0.05, ns - not significant p-value. 
(E) Morphology of the PVN of 129/Sv Mrap2tm1a/tm1a mice (right panel) compared to the wild type as 
shown by representative images of coronal brain sections (approx. bregma -0.8mm) stained by Nissl (F) 
Average PVN area size (left graph) and stereotaxic counts of Nissl positive cells (right graph) in the PVN of 
the mutant 129/sv mice (n=3) and their wild type littermates (n=3) 
 
 
 
Figure 6. Mrap2tm1a/tm1a mice exhibit fatty liver and changes in cholesterol metabolism. Morphological 
changes in the liver of 129/sv Mrap2tm1a/tm1a mutant mice as shown by H&E staining (A) and Oil Red O 
(B) suggesting lipid accumulation in Mrap2tm1a/tm1a. Scale bars = 200µm. (C-H) circulating TAG, total 
cholesterol, HDL, LDL, NEFA-C and Glycerol in 16 week C57BL/6N Mrap2tm1a/tm1a mice is shown, n=7 
for each Mrap2tm1a/tm1a group, 38 for female Mrap2+/+ and 35 for Mrap2+/+ controls gender/genotype.  
The p-values presented on graphs are either global p-values for genotype adjusted for multiple correction 
testing, or (in the cases of sexual dimorphism) the p-value is the impact of genotype for that sex. ns=not 
significant. (I) Elevated expression levels of Srebp2 in Mrap2tm1a/tm1a female mice, reduced Ldlr in male 
Mrap2tm1a/tm1a mice and expression levels of Scarb1 in female mice and male mice (n=4 for each 
genotype/gender, *p-value <0.05, ns=not significant). 
 
 
Figure 7. Phosphorylation of ACL and HSL are changed in female Mrap2tm1a/tm1a mice and insulin 
insensitivity in both genders seen at 13 weeks of age (A) Analysis of ACL phosphorylation in white fat of 
the female mutant mice compared to the wild type by immunoblotting (B) A significant increase is 
demonstrated in mutant mice by using band densitometry analysis of the ratio of phosphorylated to non-
phosphorylated ACL normalised to beta actin (C) Phosphorylation of HSL on S660 in white fat of the 
female mutant mice is decreased as assessed by western blotting (D) densitometry analysis of 
phosphorylated to non-phosphorylated HSL normalised to beta-actin was calculated (n=3 per genotype; 
129/Sv). (E) Fasting plasma glucose and (F) fed-state plasma insulin are higher in C57BL/6N 
Mrap2tm1a/tm1a mutant mice of both genders associated with significantly elevated insulin levels (log 
transformed due to the range of values seen in Mrap2tm1a/tm1a male mice). (G&H) IPGTT performed on 
13 week old mice of both genders, delayed glucose clearance demonstrated in Mrap2tm1a/tm1a female mice 
but not statistically significant in male Mrap2tm1a/tm1a mice. n=7 for each Mrap2tm1a/tm1a group, 39 for 
female Mrap2+/+ and 35 for Mrap2+/+ controls gender/genotype.  P-values presented on graphs are either 
global p-values for genotype adjusted for multiple correction testing, or (in the cases of sexual dimorphism) 
the p-value is the impact of genotype for that sex. AUC=area under the curve, ns=not significant. 
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Figure 1. Mrap2 gene disruption results in weight gain (A) Schematic of knockout first strategy for 
Mrap2. A promoter driven cassette including lacZ and neo genes are inserted upstream of critical exon 4. (B) 
Q-RT-PCR in 129/Sv mice demonstrating (i) Mrap2 expression in a range of wild type mouse tissues showing 
the highest expression levels in the hypothalamus, n=3. (ii) reduced hypothalamic Mrap2 transcript  in 
Mrap2tm1a/+ and Mrap2tm1a/tm1a compared with Mrap2+/+ mice (n=3 per genotype); mean plotted +/- SEM; ** 
p-value <0.05; *** p-value <0.0005). (C) Expression of Mrap2 in the hypothalamus of the wild type 129/Sv 
Mrap2+/+ and Mrap2tm1a/tm1a mice as shown by in situ hybridisation using coronal brain sections (approx. 
bregma – 0.6mm). AS- antisense probe, S-sense probe as a negative control. 3rd ventricle indicated as 3V, 
asterisk indicates position of the PVN, OC - optic chiasm; scale bars = 200µm (D) Weight curves of 
Mrap2tm1a/tm1a in both genders and genetic backgrounds illustrated. 129/Sv Mrap2tm1a/tm1a n>8 per genotype 
and gender, C57BL/6N Mrap2tm1a/tm1a n=7 of each gender and genotype. (E) Total body weight gain of 
C57BL/6N Mrap2tm1a/tm1a mice by the age of 16 weeks, n=7 for each gender/genotype (left) and appearance 
of the mutant mice compared to the wild type (right). Data is present as both box-and-whiskers plot 
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(showing min-mean-max values, with the box representing the 25th and 75th percentiles), and as a scatter 
dot plot for individual values. P-values presented on graphs are either global p-values for genotype adjusted 
for multiple correction testing, or (in the cases of sexual dimorphism) the p-value is the impact of genotype 
for that sex.  
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Figure 1C (high resolution) Expression of Mrap2 in the hypothalamus of the wild type 129/Sv Mrap2+/+ 
and Mrap2tm1a/tm1a mice as shown by in situ hybridisation using coronal brain sections (approx. bregma – 
0.6mm). AS- antisense probe, S-sense probe as a negative control. 3rd ventricle indicated as 3V, asterisk 
indicates position of the PVN, OC - optic chiasm; scale bars = 200µm  
23x9mm (600 x 600 DPI)  
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Figure 2. Increased fat content and lean mass in Mrap2tm1a/tm1a mice at 14 weeks (A) Increased 
fat mass in mutant C57BL/6N mice. (B) Fat mass represented as a % of body weight (C) Adipocyte 
hypertrophy as demonstrated by H&E histology of peripheral fat (representative image of inguinal white fat 
from 129/sv mice). Scale bars = 200µm. (D) Increased lean mass and (E) no difference in bone mineral 
density or content (data not shown) in Mrap2tm1a/tm1a mice (C57BL/6N) compared to Mrap2+/+. (F) Increased 
body length in the female mutant mice only (C57BL/6N). n=7 for each Mrap2tm1a/tm1a group, 34 for female 
Mrap2+/+ and 35 for Mrap2+/+ controls gender/genotype.  P-values presented on graphs are either global p-
values for genotype adjusted for multiple correction testing, or (in the cases of sexual dimorphism) the p-
value is the impact of genotype for that sex.  
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Figure 3. Food intake and energy expenditure balance in Mrap2+/+, Mrap2tm1a/+ and Mrap2tm1a/tm1a 
mice. Body weight dynamics of female (A, Mrap2+/+ n=6; Mrap2tm1a/+ n=4; Mrap2tm1a/tm1a n=10) and male 
(B, Mrap2+/+ n=6; Mrap2tm1a/+ n=7; Mrap2tm1a/tm1a n=6) mutant mice and their food intake (C and D) in 
response to a 24 hour fast (129/Sv background).  
184x136mm (72 x 72 DPI)  
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Figure 4. Male Mrap2tm1a/tm1a mice locomotor activity analysis. (A) Beam breaks/5 min in male (left, 
Mrap2+/+ n=9; Mrap2tm1a/+ n=7; Mrap2tm1a/tm1a n=11) and female (right, Mrap2+/+ n=6;  Mrap2tm1a/+ n=4; 
Mrap2tm1a/tm1a n=10) mice are shown, with male Mrap2tm1a/tm1a mice demonstrating significantly increased 
locomotor activity in their home cages during the daytime (B) Open field assessment of Mrap2tm1a/tm1a mice 
also indicate a significant increase in total time moving and distance travelled over 20 min in males (left), 
when compared to Mrap2+/+ littermates, but not females (right). (C) Representative activity traces of the 
centre-point of individual male mice (left) and female mice (right) in the open field. The colour of the trace 
indicates the velocity of the mouse from 0 cm/sec (blue) to 20cm/sec (pink). The centre of the open field is 
indicated by a dashed box.  (D) Neither male (left) nor female Mrap2tm1a/tm1a mice (right) display a 
significant difference in time spent in areas of the open field, compared to wild-type controls. n number for 
B-D is 8 per group/gender, * p-value<0.05.  
188x207mm (72 x 72 DPI)  
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Figure 5. Mrap2 is involved in Mc4r regulation in the hypothalamus. (A) An example of the 
hypothalamic section stained with cresyl violet before the microdissection (left panel) and after (right panel). 
Asterisks show the position of the PVN, 3V-third ventricle, the scale bars are 150µm. (B) Mc4r expression 
level in the PVN (Mrap2+/+ n=3, Mrap2tm1a/tm1a n=3) and in the whole hypothalamus (Mrap2+/+ n=4, 
Mrap2tm1a/tm1a n=4) as determined by the qPCR. (C) Expression of Sim1, Trh, Oxt, Avp, Crh and Sst in the 
PVN of 129/Sv wild type (n=4) and Mrap2tm1a/tm1a (n=3) mice. The data is represented as the mean of the 
microarray fluorescence values (±S.E.M), normalised to the wild type for each gene. *p-value <0.05; ** p-
value <0.05; *** p-value <0.0005 (D) Expression of Sim1, Trh, Oxt, Avp, Crh and Sst in the whole 
hypothalamus of the wild-type and Mrap2tm1a/tm1a mice as determined by the qPCR. Data from male mice 
n=4 per genotype is shown. The graph represents mean±S.E.M. *p-value <0.05, ns - not significant p-
value. (E) Morphology of the PVN of 129/Sv Mrap2tm1a/tm1a mice (right panel) compared to the wild type as 
shown by representative images of coronal brain sections (approx. bregma -0.8mm) stained by Nissl (F) 
Average PVN area size (left graph) and stereotaxic counts of Nissl positive cells (right graph) in the PVN of 
the mutant 129/sv mice (n=3) and their wild type littermates (n=3)  
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Figure 6. Mrap2tm1a/tm1a mice exhibit fatty liver and changes in cholesterol metabolism. 
Morphological changes in the liver of 129/sv Mrap2tm1a/tm1a mutant mice as shown by H&E staining (A) and 
Oil Red O (B) suggesting lipid accumulation in Mrap2tm1a/tm1a. Scale bars = 200µm. (C-H) circulating TAG, 
total cholesterol, HDL, LDL, NEFA-C and Glycerol in 16 week C57BL/6N Mrap2tm1a/tm1a mice is shown, n=7 for 
each Mrap2tm1a/tm1a group, 38 for female Mrap2+/+ and 35 for Mrap2+/+ controls gender/genotype.  The p-
values presented on graphs are either global p-values for genotype adjusted for multiple correction testing, 
or (in the cases of sexual dimorphism) the p-value is the impact of genotype for that sex. ns=not significant. 
(I) Elevated expression levels of Srebp2 in Mrap2tm1a/tm1a female mice, reduced Ldlr in male Mrap2tm1a/tm1a 
mice and expression levels of Scarb1 in female mice and male mice (n=4 for each genotype/gender, *p-
value <0.05, ns=not significant).  
197x279mm (72 x 72 DPI)  
 
 
Page 31 of 33
  
 
 
Figure 7. Phosphorylation of ACL and HSL are changed in female Mrap2tm1a/tm1a mice and insulin 
insensitivity in both genders seen at 13 weeks of age (A) Analysis of ACL phosphorylation in white fat 
of the female mutant mice compared to the wild type by immunoblotting (B) A significant increase is 
demonstrated in mutant mice by using band densitometry analysis of the ratio of phosphorylated to non-
phosphorylated ACL normalised to beta actin (C) Phosphorylation of HSL on S660 in white fat of the female 
mutant mice is decreased as assessed by western blotting (D) densitometry analysis of phosphorylated to 
non-phosphorylated HSL normalised to beta-actin was calculated (n=3 per genotype; 129/Sv). (E) Fasting 
plasma glucose and (F) fed-state plasma insulin are higher in C57BL/6N Mrap2tm1a/tm1a mutant mice of both 
genders associated with significantly elevated insulin levels (log transformed due to the range of values seen 
in Mrap2tm1a/tm1a male mice). (G&H) IPGTT performed on 13 week old mice of both genders, delayed glucose 
clearance demonstrated in Mrap2tm1a/tm1a female mice but not statistically significant in male Mrap2tm1a/tm1a 
mice. n=7 for each Mrap2tm1a/tm1a group, 39 for female Mrap2+/+ and 35 for Mrap2+/+ controls 
gender/genotype.  P-values presented on graphs are either global p-values for genotype adjusted for 
multiple correction testing, or (in the cases of sexual dimorphism) the p-value is the impact of genotype for 
that sex. AUC=area under the curve, ns=not significant.  
328x365mm (72 x 72 DPI)  
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